Personalised Medicine Europe Conference
07 Jul 2014 - 08 Jul 2014 - Brussels, Belgium
With the advent of Next Generation Sequencing rapidly becoming an indispensable and extensively used tool in clinical genetics settings, the development and realisation of personalised medicine looks promising but with great challenges. The Global Personalised Medicine market is forecasted to grow at a CAGR of 12.07 percent over the period 2012-2016. The promise of personalised medicine has been built upon advancements in genomics, proteomics and metabolomics, completion of mapping the human genome and development of targeted diagnostics and therapeutics.